Bank of Montreal
SRPT icon

Bank of Montreal’s Sarepta Therapeutics SRPT Stock Holding History

Bank of Montreal’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,000
Closed -$152K – 4964
2019
Q2 		$152K Buy
+1,000
New +$122K ﹤0.01% 3079

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bank of Montreal's SRPT Position: Q2 2026 in Review

Bank of Montreal reduced its Sarepta Therapeutics (SRPT) stake by 61% in Q2 2026, selling an estimated $296K and leaving 10,185 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #3042.

Bank of Montreal first reported a position in SRPT in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.8M in Q1 2022. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Bank of Montreal held 10,185 shares of Sarepta Therapeutics worth $183K as of Q2 2026.
  • Bank of Montreal sold 15,630 Sarepta Therapeutics shares in Q2 2026, an estimated $296K.
  • Sarepta Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3042 holding.
  • Bank of Montreal first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Sarepta Therapeutics position peaked at $37.8M in Q1 2022.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.